Want to get this daily news briefing by email? Here’s the sign-up. 


WHAT WE’RE WATCHING

DEAL OR NO DEAL – A proposed settlement confirmed with Purdue Pharma on Wednesday involving thousands of lawsuits could provide some monetary assurances for cities and counties with pending opioid cases, in the likely event that the drug maker files for bankruptcy. But, as Amanda Bronstad reports, several state attorneys general are balking at the deal as inadequate.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]